Monogram Technologies - צמיחת מכירות משנה לשנה (TTM) MGRM

Pending FDA verdicts are temporarily stalling the expansion of new clinics into the robotic orthopedics ecosystem. This chart on GURU.Markets shows that the TTM sales volume growth rate has reached the parameter. Monogram Technologies (MGRM) maintains stable consumable sales through its endoprosthesis systems, while the high precision of 3D-printed implants has established an impeccable brand image for Monogram Technologies (MGRM) among surgeons.

This metric is calculated as the percentage change in revenue over the last 12 months relative to the same period last year, revealing the true strength of the fundamental trend and hidden vulnerabilities in the commercial flow. For Monogram Technologies (MGRM), which is shielded by low geopolitical risks within the US surgical robotics niche, the TTM revenue growth rate serves as an indicator of the real expansion of technologies in healthcare.